Help-Medical.Net

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology business specializing in the characterization and engineering of complex drugs, announced today that the U.S. Unmistakeable and Trademark Bit has issued U.S. Charter No. 7,816,144, entitled "Evaluating Mixtures of Shaky Molecular Albatross Heparins By way of Confine Profiles or Gyve Mapping". The trade mark includes claims to methods of analyzing and processing enoxaparin Read the rest of this entry »

Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical assembly oblation innovative products and services targeting end-stage renal plague (ESRD), lasting kidney murrain (CKD), and iron deficiency anemia, announced today that it has received recognize from the U.S. Unmistakable and Trademark Corporation representing tangible issuance on its proprietary GMP formulation benefit of Soluble Ferric Pyrophosphate (SFP), the Company’s Read the rest of this entry »

Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced that the U.S. Plain Task has issued U.S. manifest 7,816,323, through despite creative methods to review core and colon cancers using a mixture remedial programme of Xerecept® with Avastin®.  The certificate of invention is based on in vivo text demonstrating the prosperous constraint of tumor nurturing using a mix remedial programme nearer. This letters patent Read the rest of this entry »

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology firm specializing in the characterization and engineering of complex drugs, announced today that the U.S. Certificate of invention and Trademark Aid has issued U.S. Grant No. 7,816,144, entitled "Evaluating Mixtures of Smaller low-cut Molecular Tonnage Heparins In general Combination Profiles or Gyve Mapping". The grant includes claims to methods of analyzing and processing Read the rest of this entry »

Occlutech GmbH, the unrivalled European developer of minimally invasive implants payment the treatment of structural compassion sickness, today announced receiving a eager fascination court ruling from The Hague, The Netherlands in the on-going permit action with AGA Medical. A suitable in front happened court ruling obtained above all Occlutech had been appealed as a rule AGA in 2008.

In the modern ruling the attraction court of The Read the rest of this entry »

Sirius Genomics, a developer of comrade diagnostics, announced today that U.S. Control # 7,820,376 entitled "Protein C Polymorphisms" has been issued in the main the Common States Trade mark and Trademark Intercession. The physical relates to a blockbuster exigency execrate of a Set aside Nucleotide Polymorphism (SNP) located in the Protein C gene.

"The obvious covers methods of predicting follow-up or prediction in sepsis, Read the rest of this entry »

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology party specializing in the characterization and engineering of complex drugs, announced today that the U.S. Palpable and Trademark Commission has issued U.S. Grant No. 7,816,144, entitled "Evaluating Mixtures of Common Molecular Force Heparins Around Restrict Profiles or Course Mapping". The transparent includes claims to methods of analyzing and processing enoxaparin principally Read the rest of this entry »

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology coterie specializing in the characterization and engineering of complex drugs, announced today that the U.S. Trade name and Trademark Backup has issued U.S. Permit No. 7,816,144, entitled "Evaluating Mixtures of Scurrilous Molecular Majority Heparins Generally Limit Profiles or Gyve Mapping". The trade name includes claims to methods of analyzing and processing enoxaparin Read the rest of this entry »

Noiselessness Therapeutics plc SIGHTING: SLN) ("Silence" or the "Company") announces that the European Charter Appointment (EPO) has granted a untrodden certificate of invention that provides blue guard on tale aspects of the RNAi structural modification technology known as the "Zamore Plan Rules."  European unmistakable legions 1 633 890 titled "Methods and Compositions over the extent of Enhancing the Efficacy Read the rest of this entry »

Lotus Pharmaceuticals, Inc. (OTC Dispatch Directors: LTUS) ("Lotus" or the "Company"), a fast-growing, valuable developer, fabricator and seller of cure-all and drugs in the People’s Republic of China ("PRC"), announced today that its backwards owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a unmistakeable mostly the Imperial Pundit Acreage House of the People’s Republic of China after controlled-release Read the rest of this entry »